Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small-cell Lung Cancer (NSCLC) Stage IIIb/IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00614965
What this trial is testing

Irinotecan Plus Cisplatin vs Pemetrexed Plus Cisplatin as 2nd Line in NSCLC Stage IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 124
Not applicableStudy completedNCT02910999
What this trial is testing

Real-Life Study With Nivolumab (BMS-936558) in Advanced NSCLC Patients After Prior Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 868
Testing effectiveness (Phase 2)UnknownNCT05498389
What this trial is testing

EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaAdvanced Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+6 more
Shanghai EpimAb Biotherapeutics Co., Ltd. 115
Early research (Phase 1)Study completedNCT00857025
What this trial is testing

Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT05017025
What this trial is testing

Aurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic EGFR-Mutant Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Advanced Lung Non-Squamous Non-Small Cell CarcinomaMetastatic Lung Non-Squamous Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
M.D. Anderson Cancer Center 32
Early research (Phase 1)Study completedNCT00019825
What this trial is testing

Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura

Who this might be right for
Esophageal CancerLung CancerMalignant Mesothelioma+1 more
National Cancer Institute (NCI)
Not applicableUnknownNCT05497973
What this trial is testing

Psychosocial eHealth in Advanced Lung Cancer

Who this might be right for
Lung Cancer, Nonsmall Cell, Stage IIIALung Cancer Non-Small Cell Stage IIIBLung Cancer Non-Small Cell Stage III+2 more
Institut Català d'Oncologia 152
Not applicableStudy completedNCT00900094
What this trial is testing

UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+4 more
University of Michigan Rogel Cancer Center 200
Large-scale testing (Phase 3)Study completedNCT00415818
What this trial is testing

Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Transgene 148
Testing effectiveness (Phase 2)Study completedNCT00030407
What this trial is testing

Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Barbara Ann Karmanos Cancer Institute 34
Not applicableStudy completedNCT00897234
What this trial is testing

Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers

Who this might be right for
Lung Cancer
University of Minnesota 84
Not applicableStudy completedNCT00544336
What this trial is testing

Family Quality of Life Among Families With a Member Who is a Cancer Patient

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+3 more
Vanderbilt-Ingram Cancer Center 366
Testing effectiveness (Phase 2)Study completedNCT00097214
What this trial is testing

Carboplatin Plus Cetuximab for Treatment of Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 57
Post-approval studies (Phase 4)UnknownNCT02103257
What this trial is testing

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Who this might be right for
EGFR Positive Non-small Cell Lung CancerAdenocarcinoma
Betta Pharmaceuticals Co., Ltd. 192
Testing effectiveness (Phase 2)Study completedNCT01864681
What this trial is testing

Combination of Metformin With Gefitinib to Treat NSCLC

Who this might be right for
NSCLCEGFR Gene AmplificationAdvanced Cancer+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 224
Not applicableStudy completedNCT04909034
What this trial is testing

A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer

Who this might be right for
NSCLC Stage IIIB~IV
Microbio Co Ltd 15
Testing effectiveness (Phase 2)Study completedNCT01126736
What this trial is testing

Eribulin Mesylate Administered in Combination With Pemetrexed Versus Pemetrexed Alone as Second Line Therapy in Patients With Stage IIIB or IV Nonsquamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eisai Inc. 98
Testing effectiveness (Phase 2)Study completedNCT00077311
What this trial is testing

Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
AnemiaDrug/Agent Toxicity by Tissue/OrganLung Cancer+1 more
Alliance for Clinical Trials in Oncology 160
Testing effectiveness (Phase 2)Study completedNCT02108964
What this trial is testing

A Phase I/II, Multicenter, Open-label Study of EGFRmut-TKI EGF816, Administered Orally in Adult Patients With EGFRmut Solid Malignancies

Who this might be right for
Advanced Non-small Cell Lung Cancer
Novartis Pharmaceuticals 225
Large-scale testing (Phase 3)UnknownNCT00004209
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Cancer Research UK
Next Page